vs
Atmus Filtration Technologies Inc.（ATMU）与MERIT MEDICAL SYSTEMS INC（MMSI）财务数据对比。点击上方公司名可切换其他公司
Atmus Filtration Technologies Inc.的季度营收约是MERIT MEDICAL SYSTEMS INC的1.1倍（$446.6M vs $393.9M），Atmus Filtration Technologies Inc.净利率更高（10.7% vs 9.6%，领先1.1%），MERIT MEDICAL SYSTEMS INC同比增速更快（10.9% vs 9.8%），MERIT MEDICAL SYSTEMS INC自由现金流更多（$74.0M vs $31.2M），过去两年MERIT MEDICAL SYSTEMS INC的营收复合增速更高（10.3% vs 2.3%）
Atmus过滤技术公司是一家专业过滤解决方案提供商，研发、生产和销售空气、燃油、机油、液压等多场景过滤系统，服务全球汽车、重型车辆、工业设备、航空航天领域的原厂配套及售后替换市场。
梅里特医疗系统公司是一家全球性医疗设备企业，设计、生产和销售适用于心脏病学、放射学、肿瘤学、内窥镜及重症监护领域的介入和诊断产品，为全球医院及医疗机构提供微创医疗解决方案，助力提升患者疗效和临床操作效率。
ATMU vs MMSI — 直观对比
营收规模更大
ATMU
是对方的1.1倍
$393.9M
营收增速更快
MMSI
高出1.1%
9.8%
净利率更高
ATMU
高出1.1%
9.6%
自由现金流更多
MMSI
多$42.8M
$31.2M
两年增速更快
MMSI
近两年复合增速
2.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $446.6M | $393.9M |
| 净利润 | $48.0M | $38.0M |
| 毛利率 | 28.5% | 49.6% |
| 营业利润率 | 15.8% | 13.8% |
| 净利率 | 10.7% | 9.6% |
| 营收同比 | 9.8% | 10.9% |
| 净利润同比 | 19.7% | 36.0% |
| 每股收益（稀释后） | $0.58 | $0.64 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ATMUMMSI
| Q4 25 | $446.6M | $393.9M | ||
| Q3 25 | $447.7M | $384.2M | ||
| Q2 25 | $453.5M | $382.5M | ||
| Q1 25 | $416.5M | $355.4M | ||
| Q4 24 | $406.7M | $355.2M | ||
| Q3 24 | $403.7M | $339.8M | ||
| Q2 24 | $432.6M | $338.0M | ||
| Q1 24 | $426.6M | $323.5M |
净利润ATMUMMSI
| Q4 25 | $48.0M | $38.0M | ||
| Q3 25 | $54.8M | $27.8M | ||
| Q2 25 | $59.9M | $32.6M | ||
| Q1 25 | $44.7M | $30.1M | ||
| Q4 24 | $40.1M | $27.9M | ||
| Q3 24 | $43.8M | $28.4M | ||
| Q2 24 | $56.2M | $35.7M | ||
| Q1 24 | $45.5M | $28.2M |
毛利率ATMUMMSI
| Q4 25 | 28.5% | 49.6% | ||
| Q3 25 | 28.9% | 48.5% | ||
| Q2 25 | 28.9% | 48.2% | ||
| Q1 25 | 26.5% | 48.4% | ||
| Q4 24 | 26.3% | 48.7% | ||
| Q3 24 | 27.6% | 46.4% | ||
| Q2 24 | 30.5% | 47.7% | ||
| Q1 24 | 26.2% | 46.9% |
营业利润率ATMUMMSI
| Q4 25 | 15.8% | 13.8% | ||
| Q3 25 | 18.3% | 11.1% | ||
| Q2 25 | 18.0% | 12.3% | ||
| Q1 25 | 15.6% | 11.5% | ||
| Q4 24 | 13.4% | 10.3% | ||
| Q3 24 | 15.7% | 11.0% | ||
| Q2 24 | 18.4% | 13.6% | ||
| Q1 24 | 16.1% | 11.1% |
净利率ATMUMMSI
| Q4 25 | 10.7% | 9.6% | ||
| Q3 25 | 12.2% | 7.2% | ||
| Q2 25 | 13.2% | 8.5% | ||
| Q1 25 | 10.7% | 8.5% | ||
| Q4 24 | 9.9% | 7.9% | ||
| Q3 24 | 10.8% | 8.4% | ||
| Q2 24 | 13.0% | 10.6% | ||
| Q1 24 | 10.7% | 8.7% |
每股收益（稀释后）ATMUMMSI
| Q4 25 | $0.58 | $0.64 | ||
| Q3 25 | $0.66 | $0.46 | ||
| Q2 25 | $0.72 | $0.54 | ||
| Q1 25 | $0.54 | $0.49 | ||
| Q4 24 | $0.49 | $0.46 | ||
| Q3 24 | $0.52 | $0.48 | ||
| Q2 24 | $0.67 | $0.61 | ||
| Q1 24 | $0.54 | $0.48 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $236.4M | $446.4M |
| 总债务越低越好 | $570.0M | $734.0M |
| 股东权益账面价值 | $378.5M | $1.6B |
| 总资产 | $1.4B | $2.7B |
| 负债/权益比越低杠杆越低 | 1.51× | 0.46× |
8季度趋势，按日历期对齐
现金及短期投资ATMUMMSI
| Q4 25 | $236.4M | $446.4M | ||
| Q3 25 | $218.3M | $392.5M | ||
| Q2 25 | $190.8M | $341.8M | ||
| Q1 25 | $183.3M | $395.5M | ||
| Q4 24 | $184.3M | $376.7M | ||
| Q3 24 | $196.8M | $523.1M | ||
| Q2 24 | $160.5M | $636.7M | ||
| Q1 24 | $149.2M | $581.9M |
总债务ATMUMMSI
| Q4 25 | $570.0M | $734.0M | ||
| Q3 25 | $577.5M | $732.9M | ||
| Q2 25 | $585.0M | $731.8M | ||
| Q1 25 | $588.8M | $730.7M | ||
| Q4 24 | $592.5M | $729.6M | ||
| Q3 24 | $596.2M | $750.5M | ||
| Q2 24 | $600.0M | $801.3M | ||
| Q1 24 | $600.0M | $800.1M |
股东权益ATMUMMSI
| Q4 25 | $378.5M | $1.6B | ||
| Q3 25 | $336.7M | $1.5B | ||
| Q2 25 | $316.3M | $1.5B | ||
| Q1 25 | $265.3M | $1.4B | ||
| Q4 24 | $227.4M | $1.4B | ||
| Q3 24 | $221.2M | $1.3B | ||
| Q2 24 | $178.1M | $1.3B | ||
| Q1 24 | $121.8M | $1.2B |
总资产ATMUMMSI
| Q4 25 | $1.4B | $2.7B | ||
| Q3 25 | $1.3B | $2.6B | ||
| Q2 25 | $1.3B | $2.6B | ||
| Q1 25 | $1.2B | $2.5B | ||
| Q4 24 | $1.2B | $2.4B | ||
| Q3 24 | $1.2B | $2.4B | ||
| Q2 24 | $1.2B | $2.4B | ||
| Q1 24 | $1.1B | $2.3B |
负债/权益比ATMUMMSI
| Q4 25 | 1.51× | 0.46× | ||
| Q3 25 | 1.72× | 0.48× | ||
| Q2 25 | 1.85× | 0.49× | ||
| Q1 25 | 2.22× | 0.51× | ||
| Q4 24 | 2.61× | 0.53× | ||
| Q3 24 | 2.70× | 0.57× | ||
| Q2 24 | 3.37× | 0.62× | ||
| Q1 24 | 4.93× | 0.65× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $47.5M | $98.5M |
| 自由现金流经营现金流 - 资本支出 | $31.2M | $74.0M |
| 自由现金流率自由现金流/营收 | 7.0% | 18.8% |
| 资本支出强度资本支出/营收 | 3.6% | 6.2% |
| 现金转化率经营现金流/净利润 | 0.99× | 2.59× |
| 过去12个月自由现金流最近4个季度 | $148.8M | $215.7M |
8季度趋势，按日历期对齐
经营现金流ATMUMMSI
| Q4 25 | $47.5M | $98.5M | ||
| Q3 25 | $82.1M | $75.0M | ||
| Q2 25 | $44.4M | $83.3M | ||
| Q1 25 | $28.7M | $40.6M | ||
| Q4 24 | $20.0M | $68.7M | ||
| Q3 24 | $70.7M | $47.3M | ||
| Q2 24 | $22.9M | $68.5M | ||
| Q1 24 | $-8.2M | $36.2M |
自由现金流ATMUMMSI
| Q4 25 | $31.2M | $74.0M | ||
| Q3 25 | $68.9M | $52.5M | ||
| Q2 25 | $32.4M | $69.6M | ||
| Q1 25 | $16.3M | $19.5M | ||
| Q4 24 | $10.0M | $65.3M | ||
| Q3 24 | $54.3M | $38.0M | ||
| Q2 24 | $11.3M | $57.9M | ||
| Q1 24 | $-18.8M | $24.5M |
自由现金流率ATMUMMSI
| Q4 25 | 7.0% | 18.8% | ||
| Q3 25 | 15.4% | 13.7% | ||
| Q2 25 | 7.1% | 18.2% | ||
| Q1 25 | 3.9% | 5.5% | ||
| Q4 24 | 2.5% | 18.4% | ||
| Q3 24 | 13.5% | 11.2% | ||
| Q2 24 | 2.6% | 17.1% | ||
| Q1 24 | -4.4% | 7.6% |
资本支出强度ATMUMMSI
| Q4 25 | 3.6% | 6.2% | ||
| Q3 25 | 2.9% | 5.8% | ||
| Q2 25 | 2.6% | 3.6% | ||
| Q1 25 | 3.0% | 5.9% | ||
| Q4 24 | 2.5% | 1.0% | ||
| Q3 24 | 4.1% | 2.8% | ||
| Q2 24 | 2.7% | 3.1% | ||
| Q1 24 | 2.5% | 3.6% |
现金转化率ATMUMMSI
| Q4 25 | 0.99× | 2.59× | ||
| Q3 25 | 1.50× | 2.70× | ||
| Q2 25 | 0.74× | 2.56× | ||
| Q1 25 | 0.64× | 1.35× | ||
| Q4 24 | 0.50× | 2.46× | ||
| Q3 24 | 1.61× | 1.66× | ||
| Q2 24 | 0.41× | 1.92× | ||
| Q1 24 | -0.18× | 1.28× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ATMU
| Fuel Products | $219.1M | 49% |
| Lube | $84.8M | 19% |
| Air | $74.0M | 17% |
| Other | $68.7M | 15% |
| Related Party | $14.9M | 3% |
MMSI
| Other | $154.6M | 39% |
| Peripheral Intervention | $93.2M | 24% |
| Cardiac Intervention | $50.2M | 13% |
| OEM | $42.6M | 11% |
| Custom Procedural Solutions | $33.1M | 8% |
| Endoscopy Segment | $20.1M | 5% |
